Hasnain Faheem

Hasnain Faheem is listed in filings as Director at Kura Oncology, Inc.. This profile follows SEC Form 4 activity through Jun 4, 2026, including sale activity and purchase activity. Recent filings connect the profile to Kura Oncology, Inc. (KURA) and Gossamer Bio, Inc. (GOSS). The current snapshot covers public activity from Jun 24, 2024 to Jun 4, 2026. Reported amounts are shown as $306.9K to $4.8M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.